Fact CheckerSign in

NCT07351916Recruiting

Remission in Adults With Mild-to-moderate Asthma in Thailand

Source: ClinicalTrials.gov · Last updated 17 Apr 2026

Brief summary (registry, in English)

The goal of this observational study is to determine the prevalence of remission among adults with mild-to-moderate asthma, as well as the factors associated with remission in Thailand. The main question the study aims to answer is: What is the prevalence of remission among adults with severe asthma in Thailand? Participants will complete a questionnaire on asthma symptoms and undergo pulmonary function testing and a blood test once.

Status (registry)
Recruiting
Study type
Observational
Enrollment
289 (estimated)
First submitted
10 Jan 2026
Start date
1 Feb 2026
Primary completion date
31 Oct 2026
Lead sponsor
Thammasat University
Diseases
Asthma
NCT number
NCT07351916

What you commit to

  • Study type: Observational
  • Planned participants: 289
  • From 1 Feb 2026 to the primary completion date, 31 Oct 2026
  • 2 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • inability to perform spirometry or fractional exhaled nitric oxide (FeNO) test

Who the study is looking for

  • mild-to-moderate asthma
  • age 18 years or older

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (2)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Faculty of Medicine, Thammasat University
Coordinator of this site? Confirm its status
Pathum ThaniThailandRecruiting
Narongkorn Saiphoklang
Coordinator of this site? Confirm its status
Pathum ThaniThailandRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.